Ironwood Pharmaceuticals (IRWD) Assets Average (2011 - 2026)

Ironwood Pharmaceuticals has disclosed Assets Average across 16 years of filings, most recently posting $359.8 million for Q2 2026.

• In Q2 2026, Assets Average rose 7.39% year-over-year to $359.8 million; the TTM figure through Jun 2026 stood at $359.8 million (up 7.39% YoY), while the FY2025 annual figure was $373.9 million, down 9.02% from the prior year.
• Assets Average came in at $359.8 million for Q2 2026 at Ironwood Pharmaceuticals, down from $415.7 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.1 billion in Q1 2023 to a low of $335.1 million in Q2 2025.
• Average Assets Average over 5 years is $618.5 million, with a median of $436.1 million recorded in 2024.
• Year-over-year, Assets Average jumped 90.78% in 2022 and plunged 59.66% in 2024.
• Over 5 years, Assets Average stood at $1.1 billion in 2022, then plunged by 53.52% to $497.6 million in 2023, then slipped by 25.6% to $370.2 million in 2024, then climbed by 7.1% to $396.5 million in 2025, then declined by 9.24% to $359.8 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $359.8 million in Q2 2026, $415.7 million in Q1 2026, and $396.5 million in Q4 2025.